Skip to content

Discontinued — last reported Q1 '26

Net Income at other companies

IAR
Integra LifeSciencesIART
-$4.62M+81.7%
Artivion logo
ArtivionAORT
$1.42M+381%
Solventum logo
SolventumSOLV
$13M-90.5%
Vericel logo
VericelVCEL
-$6.3M+44.0%
Enovis logo
EnovisENOV
-$8.76M+84.3%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$1.76M+40.7%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's net income?
MiMedx Group (MDXG) reported net income of -$10.86M in Q1 2026.
How has MiMedx Group's net income changed year-over-year?
MiMedx Group's net income decreased by 254.6% year-over-year, from $7.02M to -$10.86M.
What is the long-term trend for MiMedx Group's net income?
Over 3 years (2022 to 2025), MiMedx Group's net income has grown at a 17.2% compound annual growth rate (CAGR), from -$30.2M to $48.58M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.